CD133 as a marker for cancer stem cells: progresses and concerns

Area of Science:

• Oncology
• Cell Biology
• Biomarker Research

Background:

• The cancer stem cell hypothesis posits these cells initiate tumors and drive metastasis.
• Targeting cancer stem cells is crucial for effective cancer treatment and cure.
• Identifying cancer stem cells requires reliable prospective isolation markers.

Purpose of the Study:

• To review the expression patterns of CD133 in various tissues.
• To critically evaluate the utility of CD133 as a marker for cancer stem cell isolation.
• To discuss limitations and potential combinations with other markers.

Main Methods:

• Literature review of studies on CD133 expression.
• Analysis of CD133's role in normal and cancerous tissues.
• Critical discussion of CD133's application in stem cell research.

Main Results:

• CD133 is widely used for stem cell identification.
• Recent studies show CD133 expression in differentiated epithelial cells.
• Tumor initiation can occur in CD133-negative cancer cells.

Conclusions:

• CD133 is not exclusively restricted to stem cells.
• CD133's utility may be enhanced when used with other markers or methods.
• Further research is needed to refine cancer stem cell isolation strategies.